|
|
Volumn 4, Issue 6, 2007, Pages 323-
|
|
Targeted therapies: The answer to individualized treatment?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ERLOTINIB;
GEFITINIB;
IMATINIB;
PHOSPHOTRANSFERASE;
SORAFENIB;
SUNITINIB;
TRASTUZUMAB;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER RESEARCH;
CANCER RESISTANCE;
CARCINOGENESIS;
CHRONIC MYELOID LEUKEMIA;
DRUG RESPONSE;
DRUG SPECIFICITY;
DRUG TARGETING;
EDITORIAL;
GASTROINTESTINAL TUMOR;
GENE EXPRESSION PROFILING;
GENE MUTATION;
HUMAN;
KIDNEY CANCER;
LUNG NON SMALL CELL CANCER;
MOLECULAR GENETICS;
PATIENT SELECTION;
PHARMACOGENOMICS;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
DRUG DELIVERY SYSTEMS;
DRUG RESISTANCE, NEOPLASM;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
NEOPLASMS;
PHOSPHOTRANSFERASES;
|
|
EID: 34249883882
PISSN: 17434254
EISSN: 17434262
Source Type: Journal
DOI: 10.1038/ncponc0837 Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|
